Daniela Anne Carusi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Placenta Accreta | 23 | 2024 | 241 | 6.440 |
Why?
|
Placenta Previa | 18 | 2024 | 126 | 6.420 |
Why?
|
Cesarean Section | 26 | 2024 | 1417 | 3.050 |
Why?
|
Delivery, Obstetric | 10 | 2022 | 952 | 1.790 |
Why?
|
Uterine Rupture | 3 | 2022 | 66 | 1.330 |
Why?
|
Labor Presentation | 3 | 2018 | 55 | 1.110 |
Why?
|
Pregnancy, Ectopic | 2 | 2018 | 146 | 1.080 |
Why?
|
Twins | 2 | 2018 | 339 | 1.070 |
Why?
|
Anesthesia, Obstetrical | 2 | 2018 | 235 | 1.020 |
Why?
|
Pregnancy | 52 | 2024 | 30198 | 1.020 |
Why?
|
Postpartum Hemorrhage | 7 | 2024 | 273 | 1.010 |
Why?
|
Hysterectomy | 10 | 2024 | 863 | 0.880 |
Why?
|
Hysterotomy | 2 | 2021 | 25 | 0.850 |
Why?
|
Placenta, Retained | 2 | 2018 | 22 | 0.760 |
Why?
|
Anesthesiology | 3 | 2019 | 1137 | 0.690 |
Why?
|
Parity | 3 | 2017 | 938 | 0.650 |
Why?
|
Reproductive Techniques, Assisted | 3 | 2022 | 503 | 0.640 |
Why?
|
Obstetric Labor Complications | 2 | 2019 | 243 | 0.600 |
Why?
|
Embryo Transfer | 3 | 2019 | 527 | 0.600 |
Why?
|
Ultrasonography, Prenatal | 4 | 2023 | 1767 | 0.550 |
Why?
|
Fertilization in Vitro | 6 | 2022 | 1302 | 0.550 |
Why?
|
Endometriosis | 2 | 2022 | 875 | 0.550 |
Why?
|
Maternal Age | 1 | 2018 | 809 | 0.500 |
Why?
|
Placenta | 11 | 2024 | 1722 | 0.500 |
Why?
|
Anesthesia, Conduction | 1 | 2018 | 263 | 0.490 |
Why?
|
Patient Selection | 2 | 2017 | 4265 | 0.480 |
Why?
|
Intention | 1 | 2017 | 348 | 0.450 |
Why?
|
Early Diagnosis | 1 | 2018 | 1195 | 0.440 |
Why?
|
Pregnancy Outcome | 9 | 2023 | 2961 | 0.440 |
Why?
|
Parturition | 1 | 2017 | 453 | 0.440 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2971 | 0.430 |
Why?
|
Trial of Labor | 3 | 2021 | 83 | 0.430 |
Why?
|
Retrospective Studies | 32 | 2024 | 81768 | 0.410 |
Why?
|
Premature Birth | 4 | 2022 | 1814 | 0.400 |
Why?
|
Cryopreservation | 2 | 2019 | 733 | 0.360 |
Why?
|
Cicatrix | 2 | 2024 | 799 | 0.350 |
Why?
|
Gestational Age | 6 | 2022 | 3615 | 0.350 |
Why?
|
Catheter-Related Infections | 1 | 2013 | 275 | 0.340 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 346 | 0.330 |
Why?
|
Female | 53 | 2024 | 397050 | 0.310 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 536 | 0.300 |
Why?
|
Uterus | 3 | 2024 | 661 | 0.300 |
Why?
|
Oxytocics | 2 | 2024 | 67 | 0.280 |
Why?
|
Uterine Hemorrhage | 2 | 2020 | 240 | 0.280 |
Why?
|
Uterine Artery Embolization | 3 | 2017 | 62 | 0.270 |
Why?
|
Risk Factors | 17 | 2023 | 74954 | 0.270 |
Why?
|
Abortion, Spontaneous | 3 | 2019 | 539 | 0.260 |
Why?
|
Ultrasonography | 1 | 2018 | 6001 | 0.250 |
Why?
|
Carboprost | 1 | 2024 | 3 | 0.240 |
Why?
|
Methylergonovine | 1 | 2024 | 8 | 0.240 |
Why?
|
Uterine Inertia | 1 | 2024 | 29 | 0.240 |
Why?
|
Blood Transfusion | 3 | 2022 | 1309 | 0.220 |
Why?
|
Humans | 55 | 2024 | 768298 | 0.220 |
Why?
|
Maternal Health Services | 2 | 2019 | 471 | 0.210 |
Why?
|
Gynatresia | 1 | 2022 | 11 | 0.210 |
Why?
|
Abortifacient Agents, Nonsteroidal | 2 | 2017 | 65 | 0.190 |
Why?
|
Pregnancy Trimester, First | 2 | 2017 | 921 | 0.190 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2017 | 518 | 0.180 |
Why?
|
Adult | 23 | 2024 | 223622 | 0.180 |
Why?
|
Cervix Uteri | 2 | 2015 | 577 | 0.180 |
Why?
|
Thrombelastography | 1 | 2022 | 194 | 0.170 |
Why?
|
Odds Ratio | 3 | 2017 | 9681 | 0.170 |
Why?
|
Venous Thromboembolism | 1 | 2013 | 1881 | 0.170 |
Why?
|
Home Childbirth | 1 | 2019 | 55 | 0.160 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2018 | 83 | 0.160 |
Why?
|
Live Birth | 3 | 2019 | 516 | 0.150 |
Why?
|
Mandatory Testing | 1 | 1998 | 23 | 0.150 |
Why?
|
Blood Loss, Surgical | 2 | 2020 | 642 | 0.150 |
Why?
|
Dilatation and Curettage | 1 | 2017 | 53 | 0.140 |
Why?
|
Vaginal Birth after Cesarean | 1 | 2017 | 63 | 0.140 |
Why?
|
Perinatal Care | 1 | 2019 | 245 | 0.140 |
Why?
|
Hyponatremia | 1 | 2019 | 280 | 0.130 |
Why?
|
Blastocyst | 1 | 2019 | 432 | 0.130 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 523 | 0.130 |
Why?
|
Morbidity | 2 | 2023 | 1758 | 0.130 |
Why?
|
Pregnancy Rate | 2 | 2019 | 655 | 0.130 |
Why?
|
Boston | 3 | 2019 | 9371 | 0.130 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2018 | 289 | 0.130 |
Why?
|
Prenatal Diagnosis | 2 | 2020 | 1274 | 0.120 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 575 | 0.120 |
Why?
|
Treatment Refusal | 1 | 1998 | 432 | 0.120 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2015 | 156 | 0.110 |
Why?
|
Young Adult | 5 | 2020 | 60048 | 0.110 |
Why?
|
Labor, Induced | 1 | 2015 | 156 | 0.110 |
Why?
|
Lacerations | 1 | 2015 | 149 | 0.110 |
Why?
|
Japan | 1 | 2018 | 1418 | 0.110 |
Why?
|
Phlebitis | 1 | 2013 | 35 | 0.110 |
Why?
|
Methotrexate | 2 | 2017 | 1722 | 0.110 |
Why?
|
Logistic Models | 3 | 2018 | 13323 | 0.110 |
Why?
|
Incidence | 4 | 2022 | 21544 | 0.100 |
Why?
|
Varicose Veins | 1 | 2014 | 157 | 0.100 |
Why?
|
Parenteral Nutrition, Total | 1 | 2013 | 304 | 0.100 |
Why?
|
Endometrium | 1 | 2015 | 407 | 0.100 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1259 | 0.100 |
Why?
|
Patient Transfer | 1 | 2019 | 793 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2018 | 1186 | 0.090 |
Why?
|
Cohort Studies | 5 | 2022 | 41791 | 0.090 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1998 | 1360 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1642 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2024 | 65365 | 0.090 |
Why?
|
Control Groups | 2 | 2020 | 107 | 0.090 |
Why?
|
Program Evaluation | 1 | 2018 | 2505 | 0.080 |
Why?
|
Infant, Newborn | 6 | 2022 | 26410 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3438 | 0.080 |
Why?
|
Birth Weight | 3 | 2022 | 2114 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.080 |
Why?
|
Estradiol | 1 | 2015 | 1952 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3622 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2005 | 0.070 |
Why?
|
Recurrence | 2 | 2023 | 8501 | 0.070 |
Why?
|
Middle Aged | 6 | 2020 | 223463 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1998 | 2185 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2018 | 15854 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2023 | 22292 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7453 | 0.060 |
Why?
|
Developmental Disabilities | 1 | 2013 | 1516 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2783 | 0.060 |
Why?
|
Hospitals | 1 | 2017 | 3905 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2034 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3858 | 0.050 |
Why?
|
Misoprostol | 1 | 2003 | 94 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12092 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 24316 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2023 | 584 | 0.040 |
Why?
|
Culture Media | 1 | 2022 | 898 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4847 | 0.040 |
Why?
|
Databases, Factual | 1 | 2015 | 8072 | 0.040 |
Why?
|
Embryo Culture Techniques | 1 | 2019 | 84 | 0.040 |
Why?
|
Hematocrit | 1 | 2020 | 625 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18472 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15455 | 0.040 |
Why?
|
Delphi Technique | 2 | 2019 | 888 | 0.040 |
Why?
|
Maternal Mortality | 1 | 2020 | 307 | 0.030 |
Why?
|
Oocyte Retrieval | 1 | 2018 | 162 | 0.030 |
Why?
|
Time Factors | 1 | 2018 | 40267 | 0.030 |
Why?
|
California | 1 | 2021 | 1443 | 0.030 |
Why?
|
Uterine Artery | 1 | 2015 | 30 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8615 | 0.030 |
Why?
|
Hysteroscopy | 1 | 2015 | 62 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7458 | 0.030 |
Why?
|
Myometrium | 1 | 2015 | 174 | 0.030 |
Why?
|
Balloon Occlusion | 1 | 2015 | 131 | 0.030 |
Why?
|
Ligation | 1 | 2015 | 445 | 0.030 |
Why?
|
Mothers | 1 | 2023 | 2211 | 0.030 |
Why?
|
Infant, Premature | 1 | 2022 | 2125 | 0.030 |
Why?
|
Weight Gain | 1 | 2022 | 2358 | 0.020 |
Why?
|
HIV Infections | 1 | 1998 | 17575 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2015 | 418 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 2014 | 737 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12457 | 0.020 |
Why?
|
Perception | 1 | 1997 | 1206 | 0.020 |
Why?
|
Functional Laterality | 1 | 1997 | 2268 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3212 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8902 | 0.020 |
Why?
|
Abortion, Induced | 1 | 2014 | 475 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5878 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26373 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9635 | 0.020 |
Why?
|
Adolescent | 1 | 2015 | 89182 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20224 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1994 | 6034 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3722 | 0.010 |
Why?
|
Cervical Ripening | 1 | 2003 | 18 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13019 | 0.010 |
Why?
|
Abortion, Legal | 1 | 2003 | 120 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 1994 | 7145 | 0.010 |
Why?
|
Male | 2 | 2013 | 364870 | 0.010 |
Why?
|
Child | 1 | 2024 | 80894 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2003 | 1672 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54921 | 0.010 |
Why?
|
Women's Health | 1 | 2003 | 2078 | 0.010 |
Why?
|
United States | 2 | 2017 | 73144 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 1994 | 8747 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1994 | 962 | 0.010 |
Why?
|
Corpus Callosum | 1 | 1997 | 754 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2003 | 3707 | 0.010 |
Why?
|
Visual Fields | 1 | 1997 | 1067 | 0.010 |
Why?
|
Observer Variation | 1 | 1994 | 2623 | 0.000 |
Why?
|
Epilepsy | 1 | 1997 | 3326 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1994 | 14736 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1994 | 59683 | 0.000 |
Why?
|
Aged | 1 | 1994 | 171544 | 0.000 |
Why?
|